6/14
08:55 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
6/14
08:43 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
6/14
08:43 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
6/7
09:04 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
High
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
6/7
08:24 am
phat
Rating for PHAT
High
Report
Rating for PHAT
6/7
08:24 am
phat
Rating for PHAT
High
Report
Rating for PHAT
5/31
08:40 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
5/31
08:24 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
5/31
08:24 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
5/24
01:04 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
5/24
12:35 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
5/24
12:35 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
5/17
10:03 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
5/17
09:53 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
5/17
09:53 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
5/10
09:33 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
5/10
09:05 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
5/10
09:05 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
5/9
02:05 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
5/9
01:51 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
5/9
01:51 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
5/8
06:02 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
5/8
06:02 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
5/3
05:06 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
5/3
04:07 pm
phat
Rating for PHAT
Medium
Report
Rating for PHAT